ALLYFLU

Serial Number 90894552
734

Registration Progress

Application Filed
Aug 20, 2021
Under Examination
May 16, 2023
Approved for Publication
Mar 21, 2023
Published for Opposition
Mar 21, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 16, 2026 145 days
Statement of Use required (all extensions used)

Trademark Image

ALLYFLU

Basic Information

Serial Number
90894552
Filing Date
August 20, 2021
Published for Opposition
March 21, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Nov 18, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Seqirus Inc.

03
Address
475 Green Oaks Parkway
Holly Springs, NC 27540

Ownership History

Seqirus Inc.

Original Applicant
03
Holly Springs, NC

Seqirus Inc.

Owner at Publication
03
Holly Springs, NC

Legal Representation

Attorney
Nancy Sabarra

USPTO Deadlines

Next Deadline
145 days remaining
NOA E-Mailed - SOU Required
Due Date
May 16, 2026

Application History

41 events
Date Code Type Description Documents
Nov 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 17, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 25, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 8, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 29, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 13, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 14, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 10, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 8, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 20, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 20, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 20, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 29, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 28, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 28, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 4, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 4, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 4, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 31, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 7, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 24, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
vaccines; vaccines for human use; flu vaccines
Class 042
Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
Class 044
Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

Classification

International Classes
005 042 044